- Home
- CCM vs LSTA Comparison
CCM vs LSTA Comparison
Compare CCM & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCM
- LSTA
- Stock Information
- Founded
- CCM 1997
- LSTA 1980
- Country
- CCM China
- LSTA United States
- Employees
- CCM N/A
- LSTA N/A
- Industry
- CCM Medical/Nursing Services
- LSTA Misc Health and Biotechnology Services
- Sector
- CCM Health Care
- LSTA Health Care
- Exchange
- CCM Nasdaq
- LSTA Nasdaq
- Market Cap
- CCM 18.2M
- LSTA 20.0M
- IPO Year
- CCM 2009
- LSTA N/A
- Fundamental
- Price
- CCM $4.73
- LSTA $2.39
- Analyst Decision
- CCM
- LSTA Strong Buy
- Analyst Count
- CCM 0
- LSTA 1
- Target Price
- CCM N/A
- LSTA $15.00
- AVG Volume (30 Days)
- CCM 29.8K
- LSTA 13.3K
- Earning Date
- CCM 05-02-2025
- LSTA 05-08-2025
- Dividend Yield
- CCM N/A
- LSTA N/A
- EPS Growth
- CCM N/A
- LSTA N/A
- EPS
- CCM N/A
- LSTA N/A
- Revenue
- CCM $64,910,622.00
- LSTA $1,000,000.00
- Revenue This Year
- CCM N/A
- LSTA N/A
- Revenue Next Year
- CCM N/A
- LSTA N/A
- P/E Ratio
- CCM N/A
- LSTA N/A
- Revenue Growth
- CCM N/A
- LSTA N/A
- 52 Week Low
- CCM $3.80
- LSTA $1.87
- 52 Week High
- CCM $26.70
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- CCM 58.04
- LSTA 60.67
- Support Level
- CCM $3.88
- LSTA $1.91
- Resistance Level
- CCM $4.55
- LSTA $2.09
- Average True Range (ATR)
- CCM 0.39
- LSTA 0.18
- MACD
- CCM 0.07
- LSTA 0.06
- Stochastic Oscillator
- CCM 84.16
- LSTA 100.00
About CCM Concord Medical Services Holdings Limited
Concord Medical Services Holdings Ltd operates radiotherapy and diagnostic imaging centers in China. The company operates cooperative centers across several provinces and administrative regions in China. Its network includes radiotherapy centers, diagnostic imaging centers, and centers providing other treatment and diagnostic services, such as electroencephalography for the diagnosis of epilepsy, thermotherapy to increase the efficacy of and for pain relief after radiotherapy and chemotherapy, high-intensity focused ultrasound therapy for the treatment of cancer, stereotactic radiofrequency ablation for the treatment of Parkinson's Disease and refraction and tonometry for the diagnosis of ophthalmic conditions.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative therapies for the treatment of advanced solid tumors and other major diseases. Its product candidate, LSTA1, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively.